Compare · APP vs HCAT
APP vs HCAT
Side-by-side comparison of Applovin Corporation (APP) and Health Catalyst Inc (HCAT): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both APP and HCAT operate in Computer Software: Programming Data Processing (Technology), so they compete in similar markets.
- APP is the larger of the two at $103.92B, about 874.0x HCAT ($118.9M).
- APP has been more active in the news (14 items in the past 4 weeks vs 5 for HCAT).
- Both have 25 recent analyst ratings on file.
- Company
- Applovin Corporation
- Health Catalyst Inc
- Price
- -
- -
- Market cap
- $103.92B
- $118.9M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Computer Software: Programming Data Processing
- Computer Software: Programming Data Processing
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2019
- News (4w)
- 14
- 5
- Recent ratings
- 25
- 25
Applovin Corporation
AppLovin Corporation engages in building a software-based platform for mobile app developers to enhance the marketing and monetization of their apps worldwide. The company's software solutions include AppDiscovery, a solution to automate, optimize, and manage user acquisition investments for business clients; and MAX, an in-app bidding solution that optimizes purchases of app ad inventory. Its business clients include various advertisers, internet platforms, and others. The company was incorporated in 2011 and is headquartered in Palo Alto, California.
Health Catalyst Inc
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its solutions include a cloud-based data platform, analytics software, and professional services. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. The company was founded in 2008 and is headquartered in South Jordan, Utah.
Latest APP
- Chief Financial Officer (CFO) Stumpf Matthew covered exercise/tax liability with 2,021 shares, decreasing direct ownership by 1% to 175,429 units (SEC Form 4)
- Director Valenzuela Victoria covered exercise/tax liability with 2,730 shares, decreasing direct ownership by 1% to 241,231 units (SEC Form 4)
- CEO Foroughi Arash Adam covered exercise/tax liability with 2,730 shares, decreasing direct ownership by 0.12% to 2,324,954 units (SEC Form 4)
- CTO Ge Xiaochuan covered exercise/tax liability with 5,459 shares, decreasing direct ownership by 0.56% to 968,735 units (SEC Form 4)
- Chief Legal Officer Cacovean Corina I covered exercise/tax liability with 1,540 shares, decreasing direct ownership by 24% to 4,787 units (SEC Form 4)
- Director Chen Herald Y converted options into 143,791 shares, gifted 100,000 shares and received a gift of 100,000 shares, increasing direct ownership by 41% to 151,245 units (SEC Form 4)
- AppLovin downgraded by BofA Securities with a new price target
- Director Vivas Eduardo gifted 213,675 shares and received a gift of 213,675 shares, decreasing direct ownership by 3% to 6,571,412 units (SEC Form 4)
- AppLovin downgraded by Piper Sandler with a new price target
- AppLovin downgraded by Wells Fargo with a new price target
Latest HCAT
- Health Catalyst downgraded by Canaccord Genuity with a new price target
- SEC Form 10-Q filed by Health Catalyst Inc
- Health Catalyst Inc filed SEC Form 8-K: Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Health Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence Company
- Health Catalyst Reports Second Quarter 2026 Results
- Health Catalyst to Announce Second Quarter 2026 Operating Results and Host Conference Call on Thursday, August 6, 2026
- Director Hoggard Green Jill was granted 80,691 shares, increasing direct ownership by 126% to 144,628 units (SEC Form 4)
- Director Larson-Green Julie was granted 80,691 shares, increasing direct ownership by 85% to 175,335 units (SEC Form 4)
- Director Nelson Steven H was granted 80,691 shares, increasing direct ownership by 52% to 235,499 units (SEC Form 4)
- Director Spencer Justin was granted 80,691 shares, increasing direct ownership by 118% to 149,263 units (SEC Form 4)